Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological Threats

Designed for rapid “plug and play” programming and stockpiling against emerging infectious agents and viral mutations

Emergence of Omicron and other COVID-19 variants underscores the need for a rapid, safe, and effective response to potential biological threats

Read more at globenewswire.com